SCHEMBL30349447

SCHEMBL30349447

COCCOC1(N)CCCCC1

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19436686 0.76 ADRB2 (0.37)
SCHEMBL6062111 0.73
SCHEMBL30816821 0.73 SMN1; SMN2 (0.35) KDM4E
Hydrochloric Acid SCHEMBL3719555 0.71
Cyclohexane SCHEMBL4856550 0.71 KDM4E (0.46) KDM4E
SCHEMBL15345297 0.70 KDM4E (0.31) KDM4E
SCHEMBL19135 0.70 LMNA (0.34)
SCHEMBL20104747 0.69 TSHR (0.31)
SCHEMBL3714910 0.69
Ammonia Solution, Strong SCHEMBL27943822 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4415818-A1 7H-PYRROLO[2,3-D]PYRIMIDINES AND PREPARATION AS DYRK1A INHIBITORS BioSplice Therapeutics, Inc. (US) 2024-08-21 EP disclosed
WO-2023064361-A1 7H-PYRROLO[2,3-D]PYRIMIDINES AND PREPARATION AS DYRK1A INHIBITORS BIOSPLICE THERAPEUTICS, INC. (US) 2023-04-20 WO disclosed